SIGLEC1 and breast cancer: The expansion of CD169 + macrophages correlates with B-cell expansion in these lymph nodes, and B-cell depletion negates the anti-metastatic effects of CD169 + macrophage deficiency, highlighting a protective role for CD169 + lymph node macrophages in breast cancer metastasis [166].